Home Clinical Trial Updates

Clinical Trial Updates

HER2-Targeted Bispecific Antibody ZW25 Shows Durable Response

Peter Hofland, Ph.D - October 2, 2019

Senior woman with lung cancer during medical visit

WCLC 2019: Updates from the Pembrolizumab Clinical Development Program

Pembrolizumab + Chemotherapy meets Primary Endpoint in Pivotal Phase III Trial in TNBC

Nader Sanai, MD, an internationally-recognized neurosurgical oncologist with clinical and research expertise in the treatment of all brain tumors and director of the Ivy Brain Tumor Center in Phoenix, Arizona, and a member of his clinical development team.

New Breast Cancer Drug has the Potential to be a Novel Therapy for Glioblastoma

US FDA to Review Isatuximab as a Potential Treatment for R/R Multiple Myeloma

The ceramic dragon fountain in the Parc Guell designed by Antoni Gaudi, Barcelona, Spain.

Combination of Targeted Therapies Improves Survival in Advanced Colorectal Cancers

Danielle Garcia - July 6, 2019

Lung radiography | Doctor examining a lung radiography

Durvalumab Shows Statistically-significant Benefit in Aggressive Lung Cancer

Peter Hofland, Ph.D - June 27, 2019

Two AbbVie scientists discuss finalizing details of an in vitro assay before conducting the study. Photo Courtesy: AbbVie |photo by Kevin J. Miyazaki/Redux

US FDA Lifts Partial Clinical Hold on Phase III Study of...

Peter Hofland, Ph.D - June 24, 2019

Brain puzzle concept

Regorafenib becomes First Drug used in Clinical Trial Platform to Investigate...

Peter Hofland, Ph.D - June 20, 2019

Acalabrutinib Significantly Improves Progression-Free Survival in Chronic Lymphocytic Leukemia

Peter Hofland, Ph.D - June 17, 2019

Blood

First Patient Enrolled in Non-Pharmaceutical Multi-Center, Triple-Negative Breast Cancer Clinical Trial

Peter Hofland, Ph.D - June 10, 2019

General views of the 55th Annual Meeting of the American Association of Clinical Oncology (ASCO) - held in the McCormick Place in Chicago, Ill. Courtesy: 2019 ? ASCO/Luke Franke 2019.

RC48-ADC Shows Clinically Meaningful Results in Advanced HER2+ Urothelial Cancer

Peter Hofland, Ph.D - June 5, 2019

General view of the 55th Annual Meeting of the American Society of Oncology (ASCO). Courtesey: 2019 ? ASCO/Kristen Norman 2019.

Changing Clinical Trial Enrollment Criteria Dramatically Increases Participation of Eligible Patients...

Peter Hofland, Ph.D - June 5, 2019

Surgeons using surgical instruments for keyhole surgery, watching the monitor which displays images from inside the patient's abdomen - operating theater with lights in the background.

Laparoscopic Surgery vs. Open Surgery in Patients with Colorectal Cancer with...

Peter Hofland, Ph.D - June 4, 2019

Results of Liso-Cel in Patients with Difficult-to-Treat Blood Cancers Presented at...

Peter Hofland, Ph.D - June 4, 2019

12 3...17 Page 1 of 17

LATEST

Federal Grant helps TGen Refine Cancer-detection Blood Tests for Breast Cancer Patients

Danielle Garcia - October 15, 2019

Zymeworks Awarded Best ADC Platform Technology at Annual Event

Peter Hofland, Ph.D - October 11, 2019

Nobel Prize in Physiology or Medicine 2019: How do Cells Sense and Adapt to...

Peter Hofland, Ph.D - October 10, 2019